Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sunshine Biopharma
(NQ:
SBFM
)
2.345
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sunshine Biopharma
< Previous
1
2
3
4
5
6
7
8
9
Next >
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%
November 06, 2024
Via
ACCESSWIRE
Sunshine Biopharma Launches Two New Generic Prescription Drugs
September 26, 2024
Via
ACCESSWIRE
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
September 04, 2024
Via
ACCESSWIRE
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
September 04, 2024
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY
September 04, 2024
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both...
Via
FinancialNewsMedia
Exposures
COVID-19
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada
August 26, 2024
Via
ACCESSWIRE
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%
August 19, 2024
Via
ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
August 16, 2024
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Sunshine Biopharma Announces Reverse Stock Split
August 06, 2024
Via
ACCESSWIRE
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
June 28, 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Via
InvestorPlace
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028
June 20, 2024
The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 10, 2024
Via
Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 10, 2024
Via
Benzinga
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
May 21, 2024
Via
ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024
May 20, 2024
SBFM stock results show that Sunshine Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save
May 16, 2024
Looking for the best meme stocks to sell after the Roaring Kitty rally? These three struggling companies seem to be beyond hope.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 24, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.